SCHEMBL4518075

SCHEMBL4518075

CC(=O)Nc1cnc2cccnc2c1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 1/20 0.44
HSP90AA1 P07900 1/20 0.44
HSP90AB1 P08238 1/20 0.44
ATM Q13315 1/20 0.44
SLC40A1 Q9NP59 1/20 0.42
S100A4 P26447 1/20 0.41
KDR P35968 3/20 0.40
PTK2 Q05397 1/20 0.40
PABPC1 P11940 1/20 0.39
EIF4H Q15056 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
CLK1 P49759 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL203228 0.80 HTT (0.47) MEN1KMT2ATDP1ALDH1A1HTT
SCHEMBL2707298 0.79 KMT2A (0.55) MEN1KMT2AKDM4EHSP90AA1HSP90AB1
SCHEMBL27747272 0.76 KDM4E (0.36) MEN1KMT2AKDM4EHSP90AA1SLC40A1
SCHEMBL17776539 0.73 MEN1 (0.64) MEN1KMT2AKDM4EATMSLC40A1
SCHEMBL6143237 0.73 SMN1; SMN2 (0.63) MEN1KMT2AKDM4ETDP1ALDH1A1
SCHEMBL28419223 0.72 ATM (0.59) MEN1KMT2AKDM4EHSP90AA1ATM
SCHEMBL14657710 0.72 KDM4E (0.42) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL17597171 0.72 KDM4E (0.57) MEN1KMT2AKDM4EHSP90AA1ATM
SCHEMBL28419838 0.71 SLC40A1 (0.54) MEN1KMT2AATMSLC40A1KDR
SCHEMBL29918706 0.70 TDP1 (0.71) MEN1KMT2AKDM4ESLC40A1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090240055-A1 Method for 1H-Imidazo[4,5-C] Pyridines and Analogs Thereof KREPSKI LARRY R 2009-09-24 US disclosed
CN-101312975-A Method for 1h-imidazo[4,5-c]pyridines and analogs thereof COLEY PHARM GROUP INC (US) 2008-11-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240055-A1 Method for 1H-Imidazo[4,5-C] Pyridines and Analogs Thereof CYP4B1, CYP4F8, CYP4X1 MEN1 205/4885KMT2A 2015/4885KDM4E 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.